Read this new Whitepaper from WuXi Biologics.

  • Innovative platforms across key stages of TCE drug discovery, with real-world case studies on high-purity production and fit-for-purpose in vitro & in vivo studies.
  • Proven approaches to navigate key development challenges, such as structural complexity, CRS risks, and tumour heterogeneity.
  • Forward-looking strategies combining TCEs with immunomodulatory domains or checkpoint inhibitors.

Download your copy now.